Armata Pharmaceuticals, Inc.
ARMP
$1.42
$0.06815.04%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 72.60% | 30.50% | -81.37% | -86.65% | -87.03% |
| Total Depreciation and Amortization | 36.32% | 33.98% | 23.36% | 18.19% | 8.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -158.95% | -73.03% | 31,333.33% | 534.73% | 875.72% |
| Change in Net Operating Assets | 78.24% | 73.28% | 88.10% | 64.93% | -2,297.27% |
| Cash from Operations | 20.82% | 24.24% | 23.58% | 13.11% | -46.00% |
| Capital Expenditure | 76.93% | 17.64% | -145.13% | -60.20% | -268.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 76.90% | 17.83% | -144.81% | -59.95% | -267.89% |
| Total Debt Issued | -35.42% | -35.42% | 104.23% | 100.45% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,500.00% | 2,500.00% | 335.48% | 51.61% | -99.99% |
| Repurchase of Common Stock | -41.86% | -- | -- | 70.55% | 70.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -35.25% | -34.78% | 107.88% | 104.72% | 22.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -185.02% | -359.04% | 155.36% | 158.09% | -116.83% |